全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Dynamics in the Prevalence of Insulin Resistance between 2005 and 2023 in Type 2 Diabetics in South Kivu in the East of the Democratic Republic of Congo: Cross-Sectional Studies

DOI: 10.4236/jdm.2024.141004, PP. 28-40

Keywords: Prevalence, Diabetes Mellitus, Insulin Resistance, Metabolic Syndrome, South Kivu

Full-Text   Cite this paper   Add to My Lib

Abstract:

Aim: Sub-Saharan Africa is undergoing an epidemiological transition responsible for a change in the metabolic profile in favour of insulin resistance. The aim of this study was to assess the dynamics of the prevalence of insulin resistance and associated risk factors in diabetic patients in the Democratic Republic of Congo between 2005 and 2023. Method: We measured fasting blood glucose and insulin levels and looked for metabolic syndrome parameters (2009 criteria) in type 2 diabetes patients in 2005-2008 (n = 176) and in 2018-2023 (n = 303). The HOMA model was used to measure insulin sensitivity and islet β-cell secretory function. Results: Between 2005 and 2013, the trend was towards an increase in the prevalence of insulin resistance (from 13.1% to 50.8%; p < 0.0001), obesity (from 17.0% to 31.7%; p = 0.0005) and abdominal obesity (from 32.4% to 49.8%; p = 0.0002). Diabetes mellitus without insulin resistance remained more prevalent in rural than in urban areas (60.2% vs. 24.5%; p < 0.0001). Finally, the Triglycerides/HDL-C ratio [AUC = 0.513 (0.46 - 0.56); p = 0.64] and the metabolic syndrome [AUC = 0.539 (0.49 - 0.58), p = 0.12] were not predictive of insulin resistance. Conclusion: This present study shows an increase in insulin resistance in Congolese urban areas and a persistence of atypical diabetes mellitus in Congolese rural areas, confirming the particularity of the pathophysiology of the disease in African areas currently influenced by the epidemiological transition. Further studies using an appropriate methodology are required.

References

[1]  Freeman, A.M., Acevedo, L.A. and Pennings, N. (2023) Insulin Resistance. StatPearls Publishing, Treasure Island (FL).
[2]  Reimann, M., Schutte, A.E. and Schwarz, P.E. (2007) Insulin resistance—The Role of Ethnicity: Evidence from Caucasian and African Cohorts. Hormone and Metabolic Research, 39, 853-857.
https://doi.org/10.1055/s-2007-993152
[3]  Reaven, G.M. (1988) Role of Insulin Resistance in Human Disease. Diabetes, 37, 1595-1607.
https://doi.org/10.2337/diabetes.37.12.1595
[4]  WHO (2020) The Top 10 Causes of Death.
https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
[5]  Mapatano, M.A., Muyer, M.C., Buntinx, F., De Clerck, M., Okitolonda, W., Bieleli, I.A., et al. (2007) Obesity in Diabetic Patients in Kinshasa, Democratic Republic of Congo. Acta Clinica Belgica, 62, 293-297.
https://doi.org/10.1179/acb.2007.044
[6]  Katchunga, P., Hermans, M.P., Manwa, B., Lepira, F., Kashongwe, Z. and M’Buyamba-Kabangu, J.R. (2010) Hypertension artérielle, insulinorésistance et maladie rénale chronique dans un groupe de diabétiques de type 2 du Sud-Kivu, RD Congo. Néphrologie & Thérapeutique, 6, 520-525.
https://doi.org/10.1016/j.nephro.2010.04.002
[7]  Goedecke, J.H., Levitt, N.S., Lambert ,EV., Utzschneider, K.M., Faulenbach, M.V., Dave, J.A., et al. (2009) Differential Effects of Abdominal Adipose Tissue Distribution on Insulin Sensitivity in Black and White South African Women. Obesity, 17, 1506-1512.
https://doi.org/10.1038/oby.2009.73
[8]  Goedecke, J.H. and Mendham, A.E. (2022) Pathophysiology of Type 2 Diabetes in Sub-Saharan Africans. Diabetologia, 65, 1967-1980.
https://doi.org/10.1007/s00125-022-05795-2
[9]  Santosa, A., Wall, S., Fottrell, E., Högberg, U. and Byass, P. (2014) The Development and Experience of Epidemiological Transition Theory over Four Decades: A Systematic Review. Glob Health Action, 7, Article 23574.
https://doi.org/10.3402/gha.v7.23574
[10]  Katchunga, P., Masumbuko, B., Belma, M., Kashongwe Munogolo, Z., Hermans, M.P. and M’buyamba-Kabangu, J.R. (2012) Age and Living in an Urban Environment Are Major Determinants of Diabetes among South Kivu Congolese Adults. Diabetes & Metabolism, 38, 324-331.
https://doi.org/10.1016/j.diabet.2012.02.008
[11]  American Diabetes Association (2022) Standards of Medical Care in Diabetes-2022. Diabetes Care, 45, S1-S2.
https://doi.org/10.2337/dc22-Sint
[12]  Hermans, M.P. (2007) Diabetic Macro- and Microvascular Disease in Type 2 Diabetes. Diabetes & Vascular Disease Research, 4, S7-S11.
https://doi.org/10.3132/dvdr.2007.019
[13]  Alberti, K.G., Zimmet, P. and Shaw, J. (2005) IDF Epidemiology Task Force Consensus Group. The Metabolic Syndrome: A New Worldwide Definition. Lancet, 366, 1059-1062.
https://doi.org/10.1016/S0140-6736(05)67402-8
[14]  Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., et al. (2009) Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the I.D.F Task Force on Epidemiology and Prevention; NHL and Blood Institute; AHA; WHF; IAS; and IA for the Study of Obesity. Circulation, 120, 1640-1645.
https://doi.org/10.1161/CIRCULATIONAHA.109.192644
[15]  Browning, L.M., Hsieh, S.D. and Ashwell, M. (2010) A Systematic Review of Waist-to-Height Ratio as a Screening Tool for the Prediction of Cardiovascular Disease and Diabetes: 0.5 Could Be a Suitable Global Boundary Value. Nutrition Research Reviews, 23, 247-269
https://doi.org/10.1017/S0954422410000144
[16]  Gharipour, M., Sadeghi, M., Nezafati, P., Dianatkhah, M. and Sarrafzadegan, N. (2019) Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria. Journal of Research in Health Science, 19, e00442.
https://doi.org/10.1016/j.amjcard.2016.04.055
[17]  Davids, S.F.G., Matsha, T.E., Peer, N., Erasmus, R.T. and Kengne, A.P. (2020) The 7-Year Change in the Prevalence of Insulin Resistance, Inflammatory Biomarkers, and Their Determinants in an Urban South African Population. Journal of Diabetes Research, 2020, Article ID: 3781214.
https://doi.org/10.1155/2020/3781214
[18]  Katchunga, P.B., Mirindi, P., Baleke, A., Ntaburhe, T., Twagirumukiza, M. and M’buyamba-Kabangu, J.R. (2019) The Trend in Blood Pressure and Hypertension Prevalence in the General Population of South Kivu between 2012 and 2016: Results from Two Representative Cross-Sectional Surveys—The Bukavu Observational Study. PLOS ONE, 14, e0219377.
https://doi.org/10.1371/journal.pone.0219377
[19]  Muyer, M.T., Muls, E., Mapatano, M.A., Makulo, J.R., Mvitu, M., Kimenyembo, W., et al. (2012) Diabetes and Intermediate Hyperglycaemia in Kisantu, DR Congo: A Cross-Sectional Prevalence Study. BMJ Open, 2, e001911.
https://doi.org/10.1136/bmjopen-2012-001911
[20]  Muyer, M.T.M., Botomba, S., Poka, N., Mpunga, D., Sibongwere, D.K., Peñalvo, J.L., et al. (2022) Diabetes Prevalence and Risk Factors, Underestimated without Oral Glucose Tolerance Test, in Rural Gombe-Matadi Adults, Democratic Republic of Congo, 2019. Scientific Reports, 12, Article No. 15293.
https://doi.org/10.1038/s41598-022-18658-y
[21]  World Health Organization (2010) Global Status Report on Non Communicable Disease.
https://www.who.int/chp/ncd_gl obal_status_report/en/
[22]  Atun, R., Davies, J.I., Gale, E.A.M., Bärnighausen, T., Beran, D., Kengne, A.P., et al. (2017) Diabetes in Sub-Saharan Africa: From Clinical Care to Health Policy. The Lancet Diabetes and Endocrinology, 5, 622-667.
https://doi.org/10.1016/S2213-8587(17)30181-X
[23]  Saad, F.M., Lillioja, S., Nyomba, B.L., Castillo, C., et al. (1991) Racial Differences in the Relation between Blood Pressure and Insulin Resistance. The New England Journal of Medicine, 234, 733-739.
https://doi.org/10.1056/NEJM199103143241105
[24]  Yu, S.S., Castillo, D.C., Courville, A.B. and Sumner, A.E. (2012) The Triglyceride Paradox in People of African Descent. Metabolic Syndrome and Related Disorders, 10, 77-82.
https://doi.org/10.1089/met.2011.0108

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133